About this webinar
Neuromuscular blocking agents (NMBAs) are frequently used in anaesthesia. The appropriate use of NMBAs and their pharmacologic antagonists is dependent upon accurate assessment of the neuromuscular block using objective measurements obtained through quantitative neuromuscular monitors.The American Society of Anesthesiologists (ASA) and the European Society of Anaesthesiology and Intensive Care (ESAIC) recently published, independently from one another, Practice Guidelines for the management of neuromuscular blockade recommending the use of quantitative neuromuscular monitoring in all patients receiving NMBAs.
In this webinar, clinical experts will delve into the topic of muscle relaxant usage, exploring whether current practices are too relaxed. Additionally, they will provide valuable insights and strategies to help healthcare professionals optimize their clinical practice, ultimately improving patient safety and ensuring compliance with the latest guidelines and recommendations.
The webinar is divided in two presentations:
Can't join live? Register anyway and we will send you the recording after the webinar.
This webinar is hosted by Senzime, providing innovative patient monitoring solutions such as the portable EMG-based quantitative neuromuscular monitor TetraGraph.
In this webinar, clinical experts will delve into the topic of muscle relaxant usage, exploring whether current practices are too relaxed. Additionally, they will provide valuable insights and strategies to help healthcare professionals optimize their clinical practice, ultimately improving patient safety and ensuring compliance with the latest guidelines and recommendations.
The webinar is divided in two presentations:
- Residual neuromuscular block despite reversal: How is it possible? - Dr Grant Rodney
-
Guideline-compliant during robotic and laparoscopic surgery: How does it work? - Dr. Christoph Unterbuchner, D.E.S.A
Can't join live? Register anyway and we will send you the recording after the webinar.
This webinar is hosted by Senzime, providing innovative patient monitoring solutions such as the portable EMG-based quantitative neuromuscular monitor TetraGraph.
